Exact Mass: 314.0416

Exact Mass Matches: 314.0416

Found 111 metabolites which its exact mass value is equals to given mass value 314.0416, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5'-Phosphoribosyl-N-formylglycinamide

{[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-formamidoacetamido)oxolan-2-yl]methoxy}phosphonic acid

C8H15N2O9P (314.0515)


5-phosphoribosyl-n-formylglycinamide, also known as N-formyl-gar or N-formylglycinamide ribonucleotide, is a member of the class of compounds known as glycinamide ribonucleotides. Glycinamide ribonucleotides are compounds in which the amide N atom of glycineamide is linked to the C-1 of a ribosyl (or deoxyribosyl) moiety. Nucleotides have a phosphate group linked to the C5 carbon of the ribose (or deoxyribose) moiety. 5-phosphoribosyl-n-formylglycinamide is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 5-phosphoribosyl-n-formylglycinamide can be found in a number of food items such as rosemary, mexican groundcherry, common wheat, and bitter gourd, which makes 5-phosphoribosyl-n-formylglycinamide a potential biomarker for the consumption of these food products. 5-phosphoribosyl-n-formylglycinamide exists in all living species, ranging from bacteria to humans. In humans, 5-phosphoribosyl-n-formylglycinamide is involved in few metabolic pathways, which include azathioprine action pathway, mercaptopurine action pathway, purine metabolism, and thioguanine action pathway. 5-phosphoribosyl-n-formylglycinamide is also involved in several metabolic disorders, some of which include mitochondrial DNA depletion syndrome, aICA-Ribosiduria, molybdenum cofactor deficiency, and xanthinuria type I. 5-Phosphoribosyl-N-formylglycinamide, also known as FGAR or N-formyl-GAR, belongs to the class of organic compounds known as glycinamide ribonucleotides. Glycinamide ribonucleotides are compounds in which the amide N atom of glycineamide is linked to the C-1 of a ribosyl (or deoxyribosyl) moiety. FGAR is an extremely weak basic (essentially neutral) compound (based on its pKa). FGAR is a substrate for phosphoribosylformylglycinamidine synthase. It is involved in aminoimidazole ribonucleotide biosynthesis and plays a vital role in purine metabolism as well as in the conversion of glutamine to glutamate.

   

Clorazepate

7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid

C16H11ClN2O3 (314.0458)


Clorazepate is only found in individuals that have used or taken this drug. It is a water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. [PubChem]Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Wedelolactone

3,13,14-trihydroxy-5-methoxy-8,17-dioxatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2,4,6,11,13,15-heptaen-9-one

C16H10O7 (314.0427)


Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3]. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3]. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3].

   

Laccaic acid D

9,10-Dihydro-3,6,8-trihydroxy-1-methyl-9,10-dioxo-2-anthracenecarboxylic acid, 9ci

C16H10O7 (314.0427)


Laccaic acid D is found in green vegetables. Laccaic acid D is a constituent of rhubarb rhizomes

   

Glycerylphosphorylinositol

7-(2,3-dihydroxypropanoyl)-1,2,3,4,5,6-hexahydroxy-7lambda5-phosphabicyclo[4.1.0]heptan-7-one

C9H15O10P (314.0403)


   

2'-hydroxypseudobaptigenin

5,7-dihydroxy-3-(6-hydroxy-2H-1,3-benzodioxol-5-yl)-4H-chromen-4-one

C16H10O7 (314.0427)


2-hydroxypseudobaptigenin is a member of the class of compounds known as isoflavones. Isoflavones are polycyclic compounds containing a 2-isoflavene skeleton which bears a ketone group at the C4 carbon atom. 2-hydroxypseudobaptigenin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 2-hydroxypseudobaptigenin can be found in a number of food items such as sorghum, cucurbita (gourd), rubus (blackberry, raspberry), and pineapple, which makes 2-hydroxypseudobaptigenin a potential biomarker for the consumption of these food products.

   

Wedelolactone

6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 1,8,9-trihydroxy-3-methoxy-

C16H10O7 (314.0427)


Wedelolactone is a member of the class of coumestans that is coumestan with hydroxy substituents as positions 1, 8 and 9 and a methoxy substituent at position 3. It has a role as an antineoplastic agent, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, an apoptosis inducer, a hepatoprotective agent and a metabolite. It is a member of coumestans, a delta-lactone, an aromatic ether and a polyphenol. It is functionally related to a coumestan. Wedelolactone is a natural product found in Sphagneticola calendulacea, Eclipta alba, and other organisms with data available. A member of the class of coumestans that is coumestan with hydroxy substituents as positions 1, 8 and 9 and a methoxy substituent at position 3. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3]. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3]. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3].

   

Fasciculiferin

2,3,5,10-Tetrahydroxy- [ 2 ] benzopyrano [ 4,3-b ] [ 1 ] benzopyran-7 (5H) -one

C16H10O7 (314.0427)


   

Oblonginol

5,7,5-Trihydroxy-4-methoxycoumaronochromone

C16H10O7 (314.0427)


   

5-Acetyl-1,3,6,8-tetrahydroxyanthraquinone

5-Acetyl-1,3,6,8-tetrahydroxyanthraquinone

C16H10O7 (314.0427)


   

Desmoxyphyllin A

5,7,4-Trihydroxy-5-methoxycoumaronochromone

C16H10O7 (314.0427)


   
   

1,9-Dihydroxy-4-(methylsulfinyl)-6H-indolo[3,2,1-de][1,5]naphthyridine-6-one

1,9-Dihydroxy-4-(methylsulfinyl)-6H-indolo[3,2,1-de][1,5]naphthyridine-6-one

C15H10N2O4S (314.0361)


   
   

1,3,6-trihydroxy-2-methoxymethyl-9,10-anthraquinone

1,3,6-trihydroxy-2-methoxymethyl-9,10-anthraquinone

C16H10O7 (314.0427)


   

2,3,8,10-Tetrahydroxy[2]benzopyrano[4,3-b][1]benzopyran-7(5H)-one

2,3,8,10-Tetrahydroxy [ 2 ] benzopyrano [ 4,3-b ] [ 1 ] benzopyran-7 (5H) -one

C16H10O7 (314.0427)


   

5-hydroxybowdichione

5-hydroxybowdichione

C16H10O7 (314.0427)


   

Gomphrenol

3,5,4-Trihydroxy-6,7-methylenedioxyflavone

C16H10O7 (314.0427)


   

Maybridge1_000583

Maybridge1_000583

C15H10N2O4S (314.0361)


   

4-{5-[(4-nitrobenzyl)sulfanyl]-1,3,4-oxadiazol-2-yl}pyridine

4-{5-[(4-nitrobenzyl)sulfanyl]-1,3,4-oxadiazol-2-yl}pyridine

C14H10N4O3S (314.0474)


   

2-Formylknoxiavaledin

2-Formylknoxiavaledin

C16H10O7 (314.0427)


   
   

8-methoxycoumestrol

8-methoxycoumestrol

C16H10O7 (314.0427)


   

1,3,8-Trihydroxy-9-methoxy-11H-benzofuro[2,3-b][1]benzopyran-11-one

1,3,8-Trihydroxy-9-methoxy-11H-benzofuro[2,3-b][1]benzopyran-11-one

C16H10O7 (314.0427)


   

Haematommone

Haematommone

C16H10O7 (314.0427)


   
   

11H-Benzofuro(2,3-b)(1)benzopyran-11-one, 1, 3,8-trihydroxy-2-methoxy-

11H-Benzofuro(2,3-b)(1)benzopyran-11-one, 1, 3,8-trihydroxy-2-methoxy-

C16H10O7 (314.0427)


   

CHEMBL2408966

CHEMBL2408966

C16H10O7 (314.0427)


   

1-Methoxy-2,3,6,7-bismethylendioxyxanthon

1-Methoxy-2,3,6,7-bismethylendioxyxanthon

C16H10O7 (314.0427)


   

ophioglonin

ophioglonin

C16H10O7 (314.0427)


A homoflavonoid that is isochromeno[4,3-b]chromen-7(5H)-one substituted by hydroxy groups at positions 3, 4, 8 and 10. Isolated from Ophioglossum petiolatum, it exhibits anti-HBV activity.

   

Porphyrillic acid

Porphyrillic acid

C16H10O7 (314.0427)


   

Endocrocin

Endocrocin

C16H10O7 (314.0427)


A trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by a carboxy group at position 2, a methyl group at position 3, and hydroxy groups at positions 1, 6, and 8.

   

variolaric acid

variolaric acid

C16H10O7 (314.0427)


   

Parietinic acid

Parietinic acid

C16H10O7 (314.0427)


   

8-(methoxycarbonyl)-1-hydroxy-9-oxo-9h-xanthene-3-carboxylic acid

8-(methoxycarbonyl)-1-hydroxy-9-oxo-9h-xanthene-3-carboxylic acid

C16H10O7 (314.0427)


   

SCHEMBL8976204

SCHEMBL8976204

C16H10O7 (314.0427)


   

1,3,7-Trihydroxy-8-methoxy-(1)benzofuro(2,3-b)chromen-11-one

1,3,7-Trihydroxy-8-methoxy-(1)benzofuro(2,3-b)chromen-11-one

C16H10O7 (314.0427)


   

2-Methoxy-1,3,7-trihydroxy-11H-benzofuro[2,3-b][1]benzopyran-11-one

2-Methoxy-1,3,7-trihydroxy-11H-benzofuro[2,3-b][1]benzopyran-11-one

C16H10O7 (314.0427)


   

1-Methoxy-2,3,7,8-dimethylenedioxyxanthone

1-Methoxy-2,3,7,8-dimethylenedioxyxanthone

C16H10O7 (314.0427)


   

2-hydroxypseudobaptigenin

2-hydroxypseudobaptigenin

C16H10O7 (314.0427)


   

1,6,8-trihydroxy-3-methyl-9,10-dioxoanthracene-2-carboxylic acid

NCGC00180111-02!1,6,8-trihydroxy-3-methyl-9,10-dioxoanthracene-2-carboxylic acid

C16H10O7 (314.0427)


   

Porphyrilic acid

Porphyrilic acid

C16H10O7 (314.0427)


   

Laccaic acid D

9,10-Dihydro-3,6,8-trihydroxy-1-methyl-9,10-dioxo-2-anthracenecarboxylic acid, 9ci

C16H10O7 (314.0427)


A trihydroxyanthraquinone that is that is 3,6,8-trihydroxy-9,10-anthraquinone substituted by methyl and carboxy groups at positions 1 and 2 respectively. A minor component of LAC dye together with laccaic acids A, B and C.

   

Benzophenone-2,4,5-tricarboxylic Acid

Benzophenone-2,4,5-tricarboxylic Acid

C16H10O7 (314.0427)


   

Uranium tetrafluoride

Uranium tetrafluoride

F4U (314.0444)


   

3,4-DIAMINO-THIENO[2,3-B]THIOPHENE-2,5-DICARBOXYLIC ACID DIETHYL ESTER

3,4-DIAMINO-THIENO[2,3-B]THIOPHENE-2,5-DICARBOXYLIC ACID DIETHYL ESTER

C12H14N2O4S2 (314.0395)


   

yttrium 2-methoxyethoxide

yttrium 2-methoxyethoxide

C9H21O6Y (314.0397)


   

Tesicam

4-Isoquinolinecarboxamide,N-(4-chlorophenyl)-1,2,3,4-tetrahydro-1,3-dioxo-

C16H11ClN2O3 (314.0458)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

2-Bromomethyl-4-fluorophenylboronic acid pinacol ester

2-Bromomethyl-4-fluorophenylboronic acid pinacol ester

C13H17BBrFO2 (314.0489)


   

2-(4,4,5,5,6,6,6-Heptafluorohexyl)malonic acid

2-(4,4,5,5,6,6,6-Heptafluorohexyl)malonic acid

C9H9F7O4 (314.0389)


   

ethyl 2-[3,5-bis(trifluoromethyl)phenyl]-2-oxoacetate

ethyl 2-[3,5-bis(trifluoromethyl)phenyl]-2-oxoacetate

C12H8F6O3 (314.0378)


   

2-(2-(2,2,2-Trifluoroethoxy)phenoxy)ethyl methanesulfonate

2-(2-(2,2,2-Trifluoroethoxy)phenoxy)ethyl methanesulfonate

C11H13F3O5S (314.0436)


   

2-[2-[(4,5-DICHLORO-1H-IMIDAZOL-1-YL)METHYL]PHENOXY]ETHANOHYDRAZIDE

2-[2-[(4,5-DICHLORO-1H-IMIDAZOL-1-YL)METHYL]PHENOXY]ETHANOHYDRAZIDE

C12H12Cl2N4O2 (314.0337)


   

(5-CHLORO-2-METHYL-1H-INDOL-3-YL)-ACETICACID

(5-CHLORO-2-METHYL-1H-INDOL-3-YL)-ACETICACID

C13H15ClN2O3S (314.0492)


   

ISOPROPYL 3-CHLORO-5-METHOXY-6-METHYLBENZO[B]THIOPHENE-2-CARBOXYLATE 1-OXIDE

ISOPROPYL 3-CHLORO-5-METHOXY-6-METHYLBENZO[B]THIOPHENE-2-CARBOXYLATE 1-OXIDE

C14H15ClO4S (314.038)


   

2-(4-(Bromomethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-(Bromomethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C13H17BBrFO2 (314.0489)


   

2-(4-(Bromomethyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-(Bromomethyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C13H17BBrFO2 (314.0489)


   

Copper(1+) tetrafluoroborate acetonitrile (1:1:4)

Copper(1+) tetrafluoroborate acetonitrile (1:1:4)

C8H12BCuF4N4 (314.0387)


   

(5,5-diacetyloxy-4,4-dichloropentyl) acetate

(5,5-diacetyloxy-4,4-dichloropentyl) acetate

C11H16Cl2O6 (314.0324)


   

METHYL 4-HYDROXY-6-OXO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLATE

METHYL 4-HYDROXY-6-OXO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLATE

C13H9F3N2O4 (314.0514)


   

6,7-Diethoxy-2-naphthalenesulfonyl chloride

6,7-Diethoxy-2-naphthalenesulfonyl chloride

C14H15ClO4S (314.038)


   

2-(3-(BROMOMETHYL)-2-FLUOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

2-(3-(BROMOMETHYL)-2-FLUOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

C13H17BBrFO2 (314.0489)


   

2-(5-(BROMOMETHYL)-2-FLUOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

2-(5-(BROMOMETHYL)-2-FLUOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

C13H17BBrFO2 (314.0489)


   

TERT-BUTYL4-(2-IODOETHOXY)BUTANOATE

TERT-BUTYL4-(2-IODOETHOXY)BUTANOATE

C10H19IO3 (314.0379)


   

3-oxo-2-(2-oxo-2-thiophen-2-ylethylidene)-1,4-dihydroquinoxaline-6-carboxylic acid

3-oxo-2-(2-oxo-2-thiophen-2-ylethylidene)-1,4-dihydroquinoxaline-6-carboxylic acid

C15H10N2O4S (314.0361)


   

6-Desamino-cycl amp

6-Desamino-cycl amp

C10H11N4O6P (314.0416)


   

(Z)-5-((1-(4-nitrophenyl)-1H-pyrrol-2-yl)methylene)-2-thioxoimidazolidin-4-one

(Z)-5-((1-(4-nitrophenyl)-1H-pyrrol-2-yl)methylene)-2-thioxoimidazolidin-4-one

C14H10N4O3S (314.0474)


   

1-benzyl-4-chloro-3-nitroquinolin-2(1H)-one

1-benzyl-4-chloro-3-nitroquinolin-2(1H)-one

C16H11ClN2O3 (314.0458)


   

1-(2-Furanyl)-3-(phenylthio)-3-thiophen-2-yl-1-propanone

1-(2-Furanyl)-3-(phenylthio)-3-thiophen-2-yl-1-propanone

C17H14O2S2 (314.0435)


   

7-[(3-Chlorobenzyl)oxy]-2-Oxo-2h-Chromene-4-Carbaldehyde

7-[(3-Chlorobenzyl)oxy]-2-Oxo-2h-Chromene-4-Carbaldehyde

C17H11ClO4 (314.0346)


   

4-(5-{(Z)-[(2E)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzoic acid

4-(5-{(Z)-[(2E)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzoic acid

C15H10N2O4S (314.0361)


   

p-nitrophenyl-alpha-D-glucuronide

p-nitrophenyl-alpha-D-glucuronide

C12H12NO9- (314.0512)


   

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxane-2-carboxylate

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxane-2-carboxylate

C12H12NO9- (314.0512)


   

5,7-Dihydroxy-3-(6-hydroxy-1,3-benzodioxol-5-yl)chromen-4-one

5,7-Dihydroxy-3-(6-hydroxy-1,3-benzodioxol-5-yl)chromen-4-one

C16H10O7 (314.0427)


   

1-(1,2,3,4,5,6-Hexahydroxy-7-oxo-7lambda5-phosphabicyclo[4.1.0]heptan-7-yl)-2,3-dihydroxypropan-1-one

1-(1,2,3,4,5,6-Hexahydroxy-7-oxo-7lambda5-phosphabicyclo[4.1.0]heptan-7-yl)-2,3-dihydroxypropan-1-one

C9H15O10P (314.0403)


   

N(2)-Formyl-N(1)-(5-phospho-D-ribosyl)glycinamide

N(2)-Formyl-N(1)-(5-phospho-D-ribosyl)glycinamide

C8H15N2O9P (314.0515)


A glycinamide ribonucleotide having a phosphate group at the 5-position and a formyl group on the glycine nitrogen.

   

5-chloropyridin-3-yl 1-acetyl-1H-indole-5-carboxylate

5-chloropyridin-3-yl 1-acetyl-1H-indole-5-carboxylate

C16H11ClN2O3 (314.0458)


   

2-Amino-4-(2-chlorophenyl)-6-(ethylthio)pyridine-3,5-dicarbonitrile

2-Amino-4-(2-chlorophenyl)-6-(ethylthio)pyridine-3,5-dicarbonitrile

C15H11ClN4S (314.0393)


   

5-chloropyridin-3-yl 1-acetyl-1H-indole-4-carboxylate

5-chloropyridin-3-yl 1-acetyl-1H-indole-4-carboxylate

C16H11ClN2O3 (314.0458)


   

3-(1,3-Benzodioxol-5-yl)-5-(2-furanylmethylidene)-2-imino-4-thiazolidinone

3-(1,3-Benzodioxol-5-yl)-5-(2-furanylmethylidene)-2-imino-4-thiazolidinone

C15H10N2O4S (314.0361)


   

4-[(5H-[1,2,4]triazino[5,6-b]indol-3-ylthio)methyl]-2-thiazolamine

4-[(5H-[1,2,4]triazino[5,6-b]indol-3-ylthio)methyl]-2-thiazolamine

C13H10N6S2 (314.0408)


   

[2-Hydroxy-1-(1-oxoisochromen-3-yl)butyl] hydrogen sulate

[2-Hydroxy-1-(1-oxoisochromen-3-yl)butyl] hydrogen sulate

C13H14O7S (314.046)


   

Clorazepic acid

Clorazepic acid

C16H11ClN2O3 (314.0458)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

4,5-dihydroxy-7-methoxy-9,10-dioxoanthracene-2-carboxylic acid

4,5-dihydroxy-7-methoxy-9,10-dioxoanthracene-2-carboxylic acid

C16H10O7 (314.0427)


   

8,13-dihydroxy-4-[(s)-methanesulfinyl]-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5,7,9(16),10(15),11,13-heptaen-2-one

8,13-dihydroxy-4-[(s)-methanesulfinyl]-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5,7,9(16),10(15),11,13-heptaen-2-one

C15H10N2O4S (314.0361)


   

5,18-dihydroxy-7-methyl-2,10,15-trioxatetracyclo[9.7.0.0³,⁸.0¹³,¹⁷]octadeca-1(18),3(8),4,6,11,13(17)-hexaene-9,16-dione

5,18-dihydroxy-7-methyl-2,10,15-trioxatetracyclo[9.7.0.0³,⁸.0¹³,¹⁷]octadeca-1(18),3(8),4,6,11,13(17)-hexaene-9,16-dione

C16H10O7 (314.0427)


   

20-methoxy-5,7,12,16,18-pentaoxapentacyclo[11.7.0.0³,¹¹.0⁴,⁸.0¹⁵,¹⁹]icosa-1(20),3,8,10,13,15(19)-hexaen-2-one

20-methoxy-5,7,12,16,18-pentaoxapentacyclo[11.7.0.0³,¹¹.0⁴,⁸.0¹⁵,¹⁹]icosa-1(20),3,8,10,13,15(19)-hexaen-2-one

C16H10O7 (314.0427)


   

8-hydroxy-4-methanesulfinyl-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5(16),7,9,11,14-hexaene-2,13-dione

8-hydroxy-4-methanesulfinyl-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5(16),7,9,11,14-hexaene-2,13-dione

C15H10N2O4S (314.0361)


   

1,5,8-trihydroxy-3-methyl-9,10-dioxoanthracene-2-carboxylic acid

1,5,8-trihydroxy-3-methyl-9,10-dioxoanthracene-2-carboxylic acid

C16H10O7 (314.0427)


   

(10r)-3,7,8,10-tetrahydroxy-10h-5,11-dioxatetraphen-12-one

(10r)-3,7,8,10-tetrahydroxy-10h-5,11-dioxatetraphen-12-one

C16H10O7 (314.0427)


   

8-hydroxy-4-[(s)-methanesulfinyl]-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5(16),7,9,11,14-hexaene-2,13-dione

8-hydroxy-4-[(s)-methanesulfinyl]-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5(16),7,9,11,14-hexaene-2,13-dione

C15H10N2O4S (314.0361)


   

2-acetyl-1,3,6,8-tetrahydroxyanthracene-9,10-dione

2-acetyl-1,3,6,8-tetrahydroxyanthracene-9,10-dione

C16H10O7 (314.0427)


   

5,7,13-trihydroxy-14-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

5,7,13-trihydroxy-14-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

C16H10O7 (314.0427)


   

1,3,5-trihydroxy-6-methoxy-9,10-dioxoanthracene-2-carbaldehyde

1,3,5-trihydroxy-6-methoxy-9,10-dioxoanthracene-2-carbaldehyde

C16H10O7 (314.0427)


   

1,3,7,8-tetrahydroxy-10h-5,11-dioxatetraphen-12-one

1,3,7,8-tetrahydroxy-10h-5,11-dioxatetraphen-12-one

C16H10O7 (314.0427)


   

1,3,6,9-tetrahydroxy-10h-5,11-dioxatetraphen-12-one

1,3,6,9-tetrahydroxy-10h-5,11-dioxatetraphen-12-one

C16H10O7 (314.0427)


   

8,13-dihydroxy-4-methanesulfinyl-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5,7,9(16),10(15),11,13-heptaen-2-one

8,13-dihydroxy-4-methanesulfinyl-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5,7,9(16),10(15),11,13-heptaen-2-one

C15H10N2O4S (314.0361)


   

4,7-dihydroxy-5-methoxy-9,10-dioxoanthracene-2-carboxylic acid

4,7-dihydroxy-5-methoxy-9,10-dioxoanthracene-2-carboxylic acid

C16H10O7 (314.0427)


   

1-acetyl-2,4,5,7-tetrahydroxyanthracene-9,10-dione

1-acetyl-2,4,5,7-tetrahydroxyanthracene-9,10-dione

C16H10O7 (314.0427)


   

(10s)-3,7,8,10-tetrahydroxy-10h-5,11-dioxatetraphen-12-one

(10s)-3,7,8,10-tetrahydroxy-10h-5,11-dioxatetraphen-12-one

C16H10O7 (314.0427)


   

3,5,13-trihydroxy-14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-9-one

3,5,13-trihydroxy-14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-9-one

C16H10O7 (314.0427)


   

5,7,15-trihydroxy-6-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

5,7,15-trihydroxy-6-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

C16H10O7 (314.0427)


   

5,7,15-trihydroxy-14-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

5,7,15-trihydroxy-14-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

C16H10O7 (314.0427)


   

5,7,14-trihydroxy-13-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

5,7,14-trihydroxy-13-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

C16H10O7 (314.0427)


   

5,7,14-trihydroxy-6-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

5,7,14-trihydroxy-6-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

C16H10O7 (314.0427)


   

7-(2,3-dihydroxyphenyl)-9-hydroxy-2h-[1,3]dioxolo[4,5-g]chromen-8-one

7-(2,3-dihydroxyphenyl)-9-hydroxy-2h-[1,3]dioxolo[4,5-g]chromen-8-one

C16H10O7 (314.0427)


   

1-hydroxy-8-(methoxycarbonyl)-9-oxoxanthene-3-carboxylic acid

1-hydroxy-8-(methoxycarbonyl)-9-oxoxanthene-3-carboxylic acid

C16H10O7 (314.0427)


   

1,3,4-trihydroxy-5-methoxy-9,10-dioxoanthracene-2-carbaldehyde

1,3,4-trihydroxy-5-methoxy-9,10-dioxoanthracene-2-carbaldehyde

C16H10O7 (314.0427)


   

5,13,14-trihydroxy-3-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-9-one

5,13,14-trihydroxy-3-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-9-one

C16H10O7 (314.0427)


   

10-methoxy-2,6,8,16,18-pentaoxapentacyclo[11.7.0.0³,¹¹.0⁵,⁹.0¹⁵,¹⁹]icosa-1(20),3,5(9),10,13,15(19)-hexaen-12-one

10-methoxy-2,6,8,16,18-pentaoxapentacyclo[11.7.0.0³,¹¹.0⁵,⁹.0¹⁵,¹⁹]icosa-1(20),3,5(9),10,13,15(19)-hexaen-12-one

C16H10O7 (314.0427)